SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form ARS - Annual Report to Security Holders:
SEC Accession No. 0001193125-24-099213
Filing Date
2024-04-17
Accepted
2024-04-17 16:58:59
Documents
1
Period of Report
2023-12-31
Effectiveness Date
2024-04-17

Document Format Files

Seq Description Document Type Size
1 ARS d609802dars.pdf ARS 591616
  Complete submission text file 0001193125-24-099213.txt   816189
Mailing Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080
Business Address 171 OYSTER POINT BLVD., SUITE 500 SOUTH SAN FRANCISCO CA 94080 415-865-2066
Tenaya Therapeutics, Inc. (Filer) CIK: 0001858848 (see all company filings)

IRS No.: 813789973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-40656 | Film No.: 24851805
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)